The Correlation Between High-sensitivity Cardiac Troponin Levels in Diabetic Patients' Serum and Lower Limb Lesions: Based on NHANES Data

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2025 Feb 11

PMID 39931236

Authors

Lin Li

Linxi Jiao

Danyang Yang

Jingxia Zhao

Ping Li

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the association of hypersensitive cardiac troponin (hs-cTnT), a biomarker of myocardial injury, with diabetic lower extremity disease in American adults.

Methods: We conducted a cross-sectional study (unweighted N=1,196) of diabetic patients aged 40 years or older who participated in the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2004. Logistic regression was used to assess the association of hs-cTnT with lower extremity disease, including peripheral neuropathy (as assessed by monofilament test), peripheral artery disease (as assessed by ankle-brachial index), history of foot ulcers, or amputation. All analyses are weighted.

Results: The prevalence rate of diabetic lower extremity disease was 41.6%. Adjusted hs-cTnT was significantly associated with lower limb disease in adults with diabetes. There is interaction between chronic kidney disease and hs-cTnT, which strongly interferes with the correlation between hs-cTnT and lower extremity lesions in diabetic patients.

Conclusions: Our study suggests the usefulness of hs-cTnT as a biomarker for lower extremity lesions in adults with diabetes and highlights the potential direct interaction of hs-cTnT with chronic kidney disease.

References

Sandoval Y, Smith S, Sexter A, Thordsen S, Bruen C, Carlson M . Type 1 and 2 Myocardial Infarction and Myocardial Injury: Clinical Transition to High-Sensitivity Cardiac Troponin I. Am J Med. 2017; 130(12):1431-1439.e4. DOI: 10.1016/j.amjmed.2017.05.049. View

Tahhan A, Sandesara P, Hayek S, Hammadah M, Alkhoder A, Kelli H . High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes. J Am Heart Assoc. 2018; 7(5). PMC: 5866331. DOI: 10.1161/JAHA.117.007914. View

Hicks C, Selvin E . Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes. Curr Diab Rep. 2019; 19(10):86. PMC: 6755905. DOI: 10.1007/s11892-019-1212-8. View

Kaminski M, Raspovic A, McMahon L, Strippoli G, Palmer S, Ruospo M . Risk factors for foot ulceration and lower extremity amputation in adults with end-stage renal disease on dialysis: a systematic review and meta-analysis. Nephrol Dial Transplant. 2015; 30(10):1747-66. DOI: 10.1093/ndt/gfv114. View

Santos-Gallego C, Requena-Ibanez J, Antonio R, Ishikawa K, Watanabe S, Picatoste B . Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics. J Am Coll Cardiol. 2019; 73(15):1931-1944. DOI: 10.1016/j.jacc.2019.01.056. View

Gallacher P, Miller-Hodges E, Shah A, Farrah T, Halbesma N, Blackmur J . High-sensitivity cardiac troponin and the diagnosis of myocardial infarction in patients with kidney impairment. Kidney Int. 2022; 102(1):149-159. DOI: 10.1016/j.kint.2022.02.019. View

Vrsalovic M, Vrsalovic Presecki A, Aboyans V . Cardiac troponins predict mortality and cardiovascular outcomes in patients with peripheral artery disease: A systematic review and meta-analysis of adjusted observational studies. Clin Cardiol. 2022; 45(2):198-204. PMC: 8860477. DOI: 10.1002/clc.23776. View

Gregg E, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt M, Wolz M . Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care. 2004; 27(7):1591-7. DOI: 10.2337/diacare.27.7.1591. View

Sandoval Y, Jaffe A . Type 2 Myocardial Infarction: JACC Review Topic of the Week. J Am Coll Cardiol. 2019; 73(14):1846-1860. DOI: 10.1016/j.jacc.2019.02.018. View

10.

Hicks C, Wang D, McDermott K, Matsushita K, Tang O, Echouffo-Tcheugui J . Associations of Cardiac Biomarkers With Peripheral Artery Disease and Peripheral Neuropathy in US Adults Without Prevalent Cardiovascular Disease. Arterioscler Thromb Vasc Biol. 2023; 43(8):1583-1591. PMC: 10526698. DOI: 10.1161/ATVBAHA.122.318774. View

11.

Chapman A, Adamson P, Shah A, Anand A, Strachan F, Ferry A . High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction. Circulation. 2019; 141(3):161-171. PMC: 6970546. DOI: 10.1161/CIRCULATIONAHA.119.042960. View

12.

Chuang A, Nguyen M, Kung W, Lehman S, Chew D . High-sensitivity troponin in chronic kidney disease: Considerations in myocardial infarction and beyond. Rev Cardiovasc Med. 2020; 21(2):191-203. DOI: 10.31083/j.rcm.2020.02.17. View

13.

Al-Geffari M . Comparison of different screening tests for diagnosis of diabetic peripheral neuropathy in Primary Health Care setting. Int J Health Sci (Qassim). 2013; 6(2):127-34. PMC: 3616942. DOI: 10.12816/0005988. View

14.

Rehm M, Rothenbacher D, Iacoviello L, Costanzo S, Tunstall-Pedoe H, Fitton C . Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts: the BiomarCaRE project. ESC Heart Fail. 2021; 9(1):57-65. PMC: 8788046. DOI: 10.1002/ehf2.13699. View

15.

DeFilippis A, Chapman A, Mills N, de Lemos J, Arbab-Zadeh A, Newby L . Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury. Circulation. 2019; 140(20):1661-1678. PMC: 6855329. DOI: 10.1161/CIRCULATIONAHA.119.040631. View

16.

Hicks C, Wang D, Daya N, Windham B, Ballantyne C, Matsushita K . Associations of Cardiac, Kidney, and Diabetes Biomarkers With Peripheral Neuropathy among Older Adults in the Atherosclerosis Risk in Communities (ARIC) Study. Clin Chem. 2020; 66(5):686-696. PMC: 7192523. DOI: 10.1093/clinchem/hvaa051. View

17.

Hicks C, Wang D, Matsushita K, Windham B, Selvin E . Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults : A Prospective Cohort Study. Ann Intern Med. 2020; 174(2):167-174. PMC: 7932559. DOI: 10.7326/M20-1340. View

18.

Pandey A, Vaduganathan M, Patel K, Ayers C, Ballantyne C, Kosiborod M . Biomarker-Based Risk Prediction of Incident Heart Failure in Pre-Diabetes and Diabetes. JACC Heart Fail. 2021; 9(3):215-223. PMC: 11229674. DOI: 10.1016/j.jchf.2020.10.013. View

19.

Wereski R, Kimenai D, Taggart C, Doudesis D, Lee K, Lowry M . Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction. Circulation. 2021; 144(7):528-538. PMC: 8360674. DOI: 10.1161/CIRCULATIONAHA.121.054302. View

20.

Holman R, Paul S, Bethel M, Matthews D, Neil H . 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359(15):1577-89. DOI: 10.1056/NEJMoa0806470. View